Chengpeng Yu

机构：Nanchang University, First Affiliated Hospital of Jiangxi Medical College, Tongji Hospital, First Affiliated Hospital of Nanchang University, Huazhong University of Science and Technology · ORCID：0000-0003-3938-7938

发表论文 33 篇 · 总被引 862 次 · h-index 17

代表论文

• FBXO22 promotes the development of hepatocellular carcinoma by regulating the ubiquitination and degradation of p21 (2019 · Journal of Experimental & Clinical Cancer Research · 被引 123)
• The 14-3-3σ protein promotes HCC anoikis resistance by inhibiting EGFR degradation and thereby activating the EGFR-dependent ERK1/2 signaling pathway (2020 · Theranostics · 被引 96)
• The Roles of TIF1γ in Cancer (2019 · Frontiers in Oncology · 被引 62)
• RHO GTPase family in hepatocellular carcinoma (2022 · Experimental Hematology and Oncology · 被引 61)
• LncRNA influence sequential steps of hepatocellular carcinoma metastasis (2021 · Biomedicine & Pharmacotherapy · 被引 42)
• The Roles of EphB2 in Cancer (2022 · Frontiers in Cell and Developmental Biology · 被引 38)